CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I Trial of the P97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04372641
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:18.150593+00:00
- Published At
- 2025-09-17T00:00:00+00:00
- Record Updated At
- 2025-09-17
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Aggressive Non-Hodgkin Lymphoma", "Indolent Non-Hodgkin Lymphoma", "Locally Advanced Malignant Solid Neoplasm", "Metastatic Malignant Solid Neoplasm"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-17"- protocolSection.identificationModule.nctId
"NCT04372641"- protocolSection.identificationModule.officialTitle
"A Phase I Trial of the P97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.